Not applicableStudy completedNCT01847638
What this trial is testing
Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery
Who this might be right for
CataractRetinal EdemaInflammation
Melissa Toyos 50